OCT 03, 2019 10:30 AM PDT

Healing the World with CRISPR

Presented at: CRISPR 2019
Sponsored by: MilliporeSigma
C.E. Credits: P.A.C.E. CE Florida CE
  • Marketing Segment Manager, Millipore Sigma
      Caroline is the MilliporeSigma market segment manager for genome editing and CRISPR tools and reagents. Her career has led from a BS in Biology at the University of Kansas through research interrogating bacterial and eukaryotic genomes at Washington University, St. Louis University and the Children's Hospital of Pittsburgh. Caroline came to MilliporeSigma eight years ago to serve as technical lead for custom cell line engineering projects. Her years at the genome editing bench afford her first-hand experience performing precise genome editing to create gene knockouts, gene expression tags and SNPs using ZFNs and CRISPRs. Caroline now leads CRISPR product development and coordinates the MilliporeSigma CRISPR technical teams to support customers worldwide


    CRISPR has evolved into a collection of technologies for basic research with new applications for precise gene editing, screening and chromosomal detection. With recent advances in CRISPR, therapeutic applications now extend not only to humans but also to animal health and the environment. This presentation will feature original research from Merck R&D, as well as a variety of Merck CRISPR reagents for use in screening and editing of mammalian cell lines and editing of non-mammalian model organisms.

    Learning Objectives:

    1. Using CRISPR reagents in mammalian cell lines and non-mammalian models

    2. Using CRISPR reagents for screening applications

    3. Apply real life examples of how CRISPR gene editing can improve the environment

    Show Resources
    Show Resources